(Q27851900)

English

Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer

scientific article

In more languages

Statements

scholarly article

1 reference

13 November 2016

Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer (English)

1 reference

13 November 2016

pancreatic cancer

1 reference

based on heuristic

inferred from title

16

object named as

Yasushi Yatabe

0 references

author name string

Takeshi Ogura

1

0 references

Kenji Yamao

2

0 references

Kazuo Hara

3

0 references

Nobumasa Mizuno

4

0 references

Susumu Hijioka

5

0 references

Hiroshi Imaoka

6

0 references

Akira Sawaki

7

0 references

Yasumasa Niwa

8

0 references

Masahiro Tajika

9

0 references

Shinya Kondo

10

0 references

Tsutomu Tanaka

11

0 references

Yasuhiro Shimizu

12

0 references

Vikram Bhatia

13

0 references

Kazuhide Higuchi

14

0 references

Waki Hosoda

15

0 references

publication date

May 2013

0 references

Journal of Gastroenterology

0 references

48

0 references

640-6

0 references

5

0 references

Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of K-ras codon 12 transversions with short survival in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA 19-9 as a predictor for response and survival in advanced pancreatic cancer patients treated with chemoradiotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomerase activity is detected in pancreatic cancer but not in benign tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression model for pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor-suppressive pathways in pancreatic carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the pancreas. 50 years of surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of survival data and two new rank order statistics arising in its consideration

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practical prognostic index for patients with metastatic pancreatic cancer treated with gemcitabine

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

K-ras mutational status predicts poor prognosis in unresectable pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical properties of Ha-ras encoded p21 mutants and mechanism of the autophosphorylation reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of K-ras mutations in lung carcinomas: relationship to prognosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22983505

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-012-0664-2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27851900&oldid=1540415363"